PT  - JOURNAL ARTICLE
AU  - PAOLA BERRIOS JIMENEZ
AU  - REED POPP
AU  - SEEMA SHARAN
AU  - HARSHEEN K. MANAISE
AU  - SYEDA HOORULAIN AHMED
AU  - SHIVAM BANSAL
AU  - GABRIELLE KOWKABANY
AU  - SWATHI RAIKOT
AU  - KULKAEW BELLE SUKNIAM DO
AU  - ANTHONY GEORGE
AU  - EMMANUEL GABRIEL
TI  - Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer
AID  - 10.21873/anticanres.16695
DP  - 2023 Nov 01
TA  - Anticancer Research
PG  - 4969--4974
VI  - 43
IP  - 11
4099  - http://ar.iiarjournals.org/content/43/11/4969.short
4100  - http://ar.iiarjournals.org/content/43/11/4969.full
SO  - Anticancer Res2023 Nov 01; 43
AB  - Background/Aim: Pancreatic cancer has a high mortality rate and timely treatment is imperative for favorable patient outcomes. This retrospective study aimed to identify disparities in time to treatment for pancreatic cancer based on sociodemographic factors. Patients and Methods: The study used the National Cancer Database from 2004 to 2019. A total of 423,482 patients with pancreatic cancer were included in the study. Time to first treatment, surgery, radiation, and chemotherapy were analyzed in the context of age, sex, race, Hispanic origin, insurance status, income, facility type, geographic setting, grade, stage, and Charlson-Deyo Comorbidity score (CDC). Results: All sociodemographic factors included were found to be significantly associated with disparities for time to treatment in at least one of the categories studied. Minorities, treatment at academic facilities, and patients with a high CDC score had consistently longer times to all treatment classifications. Conclusion: The analyzed sociodemographic factors affected time to pancreatic cancer treatment. Disparities in time to treatment for pancreatic cancer must be studied and understood to ameliorate the impact this cancer has on society and assure the best possible care for all communities.